Stockreport

Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drug [Yahoo! Finance]

Soleno Therapeutics, Inc.  (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview
PDF Aardvark Therapeutics is developing a therapy designed to activate certain gut receptors to prompt satiety and suppress hunger. Image credit: Shiv Pahal via Shutterstoc [Read more]